Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study).

C A, Kundan Lal Lila AR, Parikh A, Mangipudi A, Sonawane A, Kiran BH, Das B, Chopde C, Varade D, C M, Bhagwat N, Bastewad N, Shah P, Saxena P, Balamurugan R, Sahay RK, Giri R, Das S, Gupta SK, Mehendiratta S, Saran S, Saklecha S, Jethwa S, Bhandari S, Kongara S, Anjum S, Gupta S, Shah T, Chavda V, Chaturvedi A, Ch A, Zaveri H, Nayak M, Kalkoti V

Open source

DOI: 10.1016/j.metop.2026.100489
Published: 2026 Sep
Container: Metabolism open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.metop.2026.100489,
  title = {Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study).},
  author = {C A and Kundan Lal Lila AR and Parikh A and Mangipudi A and Sonawane A and Kiran BH and Das B and Chopde C and Varade D and C M and Bhagwat N and Bastewad N and Shah P and Saxena P and Balamurugan R and Sahay RK and Giri R and Das S and Gupta SK and Mehendiratta S and Saran S and Saklecha S and Jethwa S and Bhandari S and Kongara S and Anjum S and Gupta S and Shah T and Chavda V and Chaturvedi A and Ch A and Zaveri H and Nayak M and Kalkoti V},
  year = {2026},
  journal = {Metabolism open},
  doi = {10.1016/j.metop.2026.100489},
  url = {https://doi.org/10.1016/j.metop.2026.100489}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study).
AU  - C A
AU  - Kundan Lal Lila AR
AU  - Parikh A
AU  - Mangipudi A
AU  - Sonawane A
AU  - Kiran BH
AU  - Das B
AU  - Chopde C
AU  - Varade D
AU  - C M
AU  - Bhagwat N
AU  - Bastewad N
AU  - Shah P
AU  - Saxena P
AU  - Balamurugan R
AU  - Sahay RK
AU  - Giri R
AU  - Das S
AU  - Gupta SK
AU  - Mehendiratta S
AU  - Saran S
AU  - Saklecha S
AU  - Jethwa S
AU  - Bhandari S
AU  - Kongara S
AU  - Anjum S
AU  - Gupta S
AU  - Shah T
AU  - Chavda V
AU  - Chaturvedi A
AU  - Ch A
AU  - Zaveri H
AU  - Nayak M
AU  - Kalkoti V
PY  - 2026
JO  - Metabolism open
DO  - 10.1016/j.metop.2026.100489
UR  - https://doi.org/10.1016/j.metop.2026.100489
ER  -

APA

A, C., AR, K. L. L., A, P., A, M., A, S., BH, K., B, D., C, C., D, V., M, C., N, B., N, B., P, S., P, S., R, B., RK, S., R, G., S, D., SK, G., S, M., S, S., S, S., S, J., S, B., S, K., S, A., S, G., T, S., V, C., A, C., A, C., H, Z., M, N., & V, K. (2026). Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study).. Metabolism open. https://doi.org/10.1016/j.metop.2026.100489

Source records

pubmed · retrieved 2026-09-25T15:16:24.238Z